{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T18:03:28Z","timestamp":1771437808970,"version":"3.50.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04221-w","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:54:33Z","timestamp":1769133273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research progress in the diagnosis and treatment of pseudomyxoma peritonei"],"prefix":"10.1186","volume":"24","author":[{"given":"Shi","family":"Guanjun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Lubiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Haipeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Ruiqing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou","family":"Huafeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"4221_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","volume":"34","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34:196\u2013201.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","volume":"33","author":"R Mittal","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B. Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia. 2017;33:511\u20139.","journal-title":"Int J Hyperthermia"},{"key":"4221_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, Gonz\u00e1lez-Moreno S, et al. A consensus for classification and pathologic reporting of Pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified Delphi process. Am J Surg Pathol. 2016;40:14\u201326.","journal-title":"Am J Surg Pathol"},{"key":"4221_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1245\/s10434-020-08655-8","volume":"28","author":"TDJH Patrick-Brown","year":"2021","unstructured":"Patrick-Brown TDJH, Carr NJ, Swanson DM, Larsen S, Mohamed F, Flatmark K. Estimating the prevalence of pseudomyxoma peritonei in Europe using a novel statistical method. Ann Surg Oncol. 2021;28:252\u20137.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR5","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.2147\/CMAR.S264474","volume":"12","author":"F Yan","year":"2020","unstructured":"Yan F, Shi F, Li X, Yu C, Lin Y, Li Y, et al. Clinicopathological characteristics of Pseudomyxoma peritonei originated from ovaries. Cancer Manag Res. 2020;12:7569\u201378.","journal-title":"Cancer Manag Res"},{"key":"4221_CR6","doi-asserted-by":"publisher","first-page":"7459","DOI":"10.12998\/wjcc.v9.i25.7459","volume":"9","author":"XD Han","year":"2021","unstructured":"Han XD, Zhou N, Lu YY, Xu HB, Guo J, Liang L. Pseudomyxoma peritonei originating from intestinal duplication: a case report and review of the literature. World J Clin Cases. 2021;9:7459\u201367.","journal-title":"World J Clin Cases"},{"key":"4221_CR7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s13193-022-01694-5","volume":"14","author":"N Allievi","year":"2023","unstructured":"Allievi N, Samuel VM, Carr N, Shah N, Di Fabio F, Dayal S, et al. Pseudomyxoma Peritonei Arising from Urachal Mucinous Neoplasms: a case series and updated literature review. Indian J Surg Oncol. 2023;14:144\u201350.","journal-title":"Indian J Surg Oncol"},{"issue":"3","key":"4221_CR8","first-page":"145","volume":"47","author":"A Xia","year":"2020","unstructured":"Xia A, Ma RQ, Zhai XC, Lu YY, Cai Y, Shi GJ, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei:a single-center experience with 854 patients[J]. Chin J Clin Oncol. 2020;47(3):145\u201351.","journal-title":"Chin J Clin Oncol"},{"key":"4221_CR9","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/cancers16081446","volume":"16","author":"S Ionescu","year":"2024","unstructured":"Ionescu S, Marincas M, Madge OL, Dicu-Andreescu IG, Chitoran E, Rotaru V, et al. Ovarian causes of Pseudomyxoma peritonei (PMP)-A literature review. Cancers (Basel). 2024;16:1446.","journal-title":"Cancers (Basel)"},{"key":"4221_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5826214","volume":"2020","author":"Y Gong","year":"2020","unstructured":"Gong Y, Wang X, Zhu Z. Pseudomyxoma peritonei originating from transverse colon mucinous adenocarcinoma: a case report and literature review. Gastroenterol Res Pract. 2020;2020:5826214.","journal-title":"Gastroenterol Res Pract"},{"key":"4221_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000510485","volume":"37","author":"A Prabhu","year":"2021","unstructured":"Prabhu A, Brandl A, Wakama S, Sako S, Ishibashi H, Nishino E, et al. First report of a Low-Grade Pseudomyxoma peritonei originating from gall bladder. Visc Med. 2021;37:222\u20135.","journal-title":"Visc Med"},{"key":"4221_CR12","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1016\/j.radcr.2025.06.036","volume":"20","author":"P Milillo","year":"2025","unstructured":"Milillo P, Stoppino LP, Prencipe G, Piscone S, Saccone S, Lorenzo FD, et al. Pseudomyxoma peritonei originating from transverse colon mucinous adenocarcinoma: CT and MRI insights from a rare case. Radiol Case Rep. 2025;20:4604\u20139.","journal-title":"Radiol Case Rep"},{"key":"4221_CR13","doi-asserted-by":"publisher","first-page":"103564","DOI":"10.5306\/wjco.v16.i4.103564","volume":"16","author":"GJ Shi","year":"2025","unstructured":"Shi GJ, Wang C, Zhang P, Lu YY, Zhou HP, Ma RQ, et al. Pseudomyxoma peritonei originating from small intestine: A case report and review of literature. World J Clin Oncol. 2025;16:103564.","journal-title":"World J Clin Oncol"},{"key":"4221_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101488","volume":"55","author":"M Ha","year":"2024","unstructured":"Ha M, Jamieson A, Pickett J, McGinnis JM, De Greve T. Pseudomyxoma peritonei arising from mature ovarian teratoma, a rare entity: report of six cases and review of current literature. Gynecol Oncol Rep. 2024;55:101488.","journal-title":"Gynecol Oncol Rep"},{"key":"4221_CR15","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/DCR.0000000000001530","volume":"62","author":"SC Glasgow","year":"2019","unstructured":"Glasgow SC, Gaertner W, Stewart D, Davids J, Alavi K, Paquette IM, et al. The American society of colon and rectal Surgeons, clinical practice guidelines for the management of appendiceal neoplasms. Dis Colon Rectum. 2019;62:1425\u201338.","journal-title":"Dis Colon Rectum"},{"key":"4221_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","volume":"47","author":"K Govaerts","year":"2021","unstructured":"Govaerts K, Lurvink RJ, De Hingh I, Van der Speeten K, Villeneuve L, Kusamura S, et al. Appendiceal tumours and Pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021;47:11\u201335.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR17","first-page":"411","volume":"25","author":"A Mukherjee","year":"2004","unstructured":"Mukherjee A, Parvaiz A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol. 2004;25:411\u20134.","journal-title":"Eur J Gynaecol Oncol"},{"key":"4221_CR18","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.ejso.2022.06.013","volume":"48","author":"JN Feng","year":"2022","unstructured":"Feng JN, Hu AJ, Xu L, Liu LL, Liu GZ, Wang JX, et al. Prevalence and incidence of pseudomyxoma peritonei in urban China: a nationwide retrospective cohort study. Eur J Surg Oncol. 2022;48:2226\u201332.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ejso.2016.03.017","volume":"42","author":"N Ansari","year":"2016","unstructured":"Ansari N, Chandrakumaran K, Dayal S, Mohamed F, Cecil TD, Moran BJ. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours. Eur J Surg Oncol. 2016;42:1035\u201341.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071406","volume":"16","author":"X Li","year":"2024","unstructured":"Li X, Liu G, Wu W. Progress in biological research and treatment of pseudomyxoma peritonei. Cancers (Basel). 2024;16:1406.","journal-title":"Cancers (Basel)"},{"key":"4221_CR21","first-page":"1527","volume":"99","author":"Y Li","year":"2019","unstructured":"Li Y, Xu HB, Peng Z, Cui SZ, Wu W, Liang H, et al. Expert consensus statement on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of Pseudomyxoma peritonei. Natl Med J China. 2019;99:1527\u201335.","journal-title":"Natl Med J China"},{"key":"4221_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00000658-199402000-00001","volume":"219","author":"PH Sugarbaker","year":"1994","unstructured":"Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994;219:109\u201311.","journal-title":"Ann Surg"},{"key":"4221_CR23","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1046\/j.1365-2168.2000.01553.x","volume":"87","author":"J Esquivel","year":"2000","unstructured":"Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg. 2000;87:1414\u20138.","journal-title":"Br J Surg"},{"key":"4221_CR24","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/sj.bjc.6603398","volume":"95","author":"R Bibi","year":"2006","unstructured":"Bibi R, Pranesh N, Saunders MP, Wilson MS, O\u2019dwyer ST, Stern PL, et al. A specific Cadherin phenotype May characterise the disseminating yet non-metastatic behaviour of Pseudomyxoma peritonei. Br J Cancer. 2006;95:1258\u201364.","journal-title":"Br J Cancer"},{"key":"4221_CR25","unstructured":"Menon G, Ramos Santillan V. Peritoneal surface malignancies. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"4221_CR26","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jso.27890","volume":"130","author":"J Demuytere","year":"2024","unstructured":"Demuytere J, Ernst S, Ceelen W. Pathophysiology of peritoneal metastasis. J Surg Oncol. 2024;130:1299\u2013305.","journal-title":"J Surg Oncol"},{"key":"4221_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1515\/pp-2024-0016","volume":"10","author":"DS Portela","year":"2025","unstructured":"Portela DS, Jain A, Flood M, Lavelle A, Guerra G, Patel M, et al. The microbiome of pseudomyxoma peritonei: a scoping review. Pleura Peritoneum. 2025;10:35\u201350.","journal-title":"Pleura Peritoneum"},{"key":"4221_CR28","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.3390\/curroncol29050289","volume":"29","author":"Y Khamzina","year":"2022","unstructured":"Khamzina Y, King MC, Nieroda C, Merrell DS, Sardi A, Gushchin V. The role of microorganisms in appendiceal pseudomyxoma peritonei: a review. Curr Oncol. 2022;29:3576\u201384.","journal-title":"Curr Oncol"},{"key":"4221_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1485694","volume":"15","author":"F Fu","year":"2025","unstructured":"Fu F, Ma X, Weng Z, Lu Y, Xu H, Ma R. Prophylactic oophorectomy is recommended in female patients with pseudomyxoma peritonei of an appendiceal origin. Front Oncol. 2025;15:1485694.","journal-title":"Front Oncol"},{"key":"4221_CR30","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1245\/s10434-024-16860-y","volume":"32","author":"M Enblad","year":"2025","unstructured":"Enblad M, Cashin P, Ghanipour L, Graf W. Patterns of preoperative tumor markers can predict resectability and prognosis of peritoneal metastases: a clustering analysis. Ann Surg Oncol. 2025;32:3638\u201347.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR31","doi-asserted-by":"publisher","first-page":"e240260","DOI":"10.1001\/jamanetworkopen.2024.0260","volume":"7","author":"A Yousef","year":"2024","unstructured":"Yousef A, Yousef M, Zeineddine MA, More A, Fanaeian M, Chowdhury S, et al. Serum tumor markers and outcomes in patients with appendiceal adenocarcinoma. JAMA Netw Open. 2024;7:e240260.","journal-title":"JAMA Netw Open"},{"key":"4221_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1245\/s10434-012-2627-5","volume":"20","author":"PL Wagner","year":"2013","unstructured":"Wagner PL, Austin F, Sathaiah M, Magge D, Maduekwe U, Ramalingam L, et al. Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. Ann Surg Oncol. 2013;20:506\u201314.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ejso.2016.01.005","volume":"42","author":"B Menassel","year":"2016","unstructured":"Menassel B, Duclos A, Passot G, Dohan A, Payet C, Isaac S, et al. Preoperative CT and MRI prediction of non-resectability in patients treated for Pseudomyxoma peritonei from mucinous appendiceal neoplasms. Eur J Surg Oncol. 2016;42:558\u201366.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR34","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s00261-017-1092-9","volume":"42","author":"E Fonseca","year":"2017","unstructured":"Fonseca E, Martins AN, Tridente CF, Yamauchi FI, Baroni RH. Liver scalloping in pseudomyxoma peritonei. Abdom Radiol (NY). 2017;42:2003\u20134.","journal-title":"Abdom Radiol (NY)"},{"issue":"Suppl 1","key":"4221_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/1754-9485.47_12784","volume":"62","author":"H Xiang","year":"2018","unstructured":"Xiang H, Han J, Ridley WE, Ridley LJ. Scalloping of the liver: pseudomyxoma peritonei. J Med Imaging Radiat Oncol. 2018;62(Suppl 1):103.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"03","key":"4221_CR36","first-page":"323","volume":"30","author":"HM Jia","year":"2021","unstructured":"Jia HM, Wang ZQ, Wei HJ, Zhai XC. Value study of CT peritoneal carcinoma index in resectability of pseudomyxoma peritonei. Computerized Tomography Theory and Applications CT. 2021;30(03):323\u201330.","journal-title":"Computerized Tomography Theory and Applications CT"},{"issue":"02","key":"4221_CR37","first-page":"183","volume":"30","author":"HM Jia","year":"2021","unstructured":"Jia HM, Zhai XC, Wang ZQ, Wei HJ. CT value study of small intestinal loop aggregation in predicting mesenteric contracture in patients with pseudomyxoma peritonei. Comput Tomography Theory Appl CT. 2021;30(02):183\u201391.","journal-title":"Comput Tomography Theory Appl CT"},{"key":"4221_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7800-2-3","volume":"2","author":"RL Harmon","year":"2005","unstructured":"Harmon RL, Sugarbaker PH. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer. Int Semin Surg Oncol. 2005;2:3.","journal-title":"Int Semin Surg Oncol"},{"key":"4221_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-025-01843-6","volume":"25","author":"D Bai","year":"2025","unstructured":"Bai D, Shi G, Liang Y, Li F, Zheng Z, Wang Z. A radiomics-based interpretable model integrating delayed-phase CT and clinical features for predicting the pathological grade of appendiceal pseudomyxoma peritonei. BMC Med Imaging. 2025;25:300.","journal-title":"BMC Med Imaging"},{"key":"4221_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jso.20049","volume":"86","author":"E de Bree","year":"2004","unstructured":"de Bree E, Koops W, Kr\u00f6ger R, van Ruth S, Witkamp AJ, Zoetmulder FAN. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol. 2004;86:64\u201373.","journal-title":"J Surg Oncol"},{"key":"4221_CR41","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/jso.27979","volume":"130","author":"D Caruso","year":"2024","unstructured":"Caruso D, Sammartino P, Polici M, Masci G, Biacchi D, Zerunian M, et al. Imaging of peritoneal surface malignancies. J Surg Oncol. 2024;130:1203\u201312.","journal-title":"J Surg Oncol"},{"key":"4221_CR42","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","volume":"22","author":"RN Low","year":"2015","unstructured":"Low RN, Barone RM, Lucero J. Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2015;22:1708\u201315.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR43","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1245\/s10434-012-2236-3","volume":"19","author":"RN Low","year":"2012","unstructured":"Low RN, Barone RM. Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2012;19:1394\u2013401.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s00261-011-9804-z","volume":"37","author":"F Iafrate","year":"2012","unstructured":"Iafrate F, Ciolina M, Sammartino P, Baldassari P, Rengo M, Lucchesi P, et al. Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging. Abdom Imaging. 2012;37:616\u201327.","journal-title":"Abdom Imaging"},{"issue":"2","key":"4221_CR45","first-page":"155","volume":"41","author":"HP Huo","year":"2019","unstructured":"Huo HP. Clinical application of color doppler ultrasound in the diagnosis of Pseudomyxoma Peritonei. Journal of Inner Mongolia Medical University. 2019;41(2):155\u20137.","journal-title":"Journal of Inner Mongolia Medical University"},{"issue":"2","key":"4221_CR46","first-page":"227","volume":"24","author":"XW Tang","year":"2015","unstructured":"Tang XW, Huang M, Zhang QX. Clinical application of color doppler ultrasound in the diagnosis of Pseudomyxoma peritonei. Mod Med Imagelogy. 2015;24(2):227\u20138236.","journal-title":"Mod Med Imagelogy"},{"key":"4221_CR47","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1245\/s10434-023-14755-y","volume":"31","author":"K Aso","year":"2024","unstructured":"Aso K, Gohda Y, Hotta M, Minamimoto R, Shimizu Y, Uemura Y, et al. Clinical effectiveness of preoperative 18F-FDG PET\/CT in predicting pathological tumor grade in patients with Pseudomyxoma peritonei originating from appendix: A retrospective cohort study. Ann Surg Oncol. 2024;31:1990\u20135.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejso.2009.09.001","volume":"36","author":"G Passot","year":"2010","unstructured":"Passot G, Glehen O, Pellet O, Isaac S, Tychyj C, Mohamed F, et al. Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction. Eur J Surg Oncol. 2010;36:315\u201323.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR49","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1007\/s00330-019-06102-1","volume":"29","author":"M Hotta","year":"2019","unstructured":"Hotta M, Minamimoto R, Gohda Y, Igari T, Yano H. Impact of a modified peritoneal cancer index using FDG-PET\/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with Pseudomyxoma peritonei. Eur Radiol. 2019;29:5709\u201316.","journal-title":"Eur Radiol"},{"key":"4221_CR50","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1007\/s00259-016-3347-z","volume":"43","author":"J Dubreuil","year":"2016","unstructured":"Dubreuil J, Giammarile F, Rousset P, Bakrin N, Passot G, Isaac S, et al. FDG-PET\/ceCT is useful to predict recurrence of Pseudomyxoma peritonei. Eur J Nucl Med Mol Imaging. 2016;43:1630\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"4221_CR51","first-page":"195","volume":"17","author":"QY Wu","year":"2025","unstructured":"Wu QY, Lei ZY, Huang LF, et al. Progress in clinical diagnosis and treatment research of Pseudomyxoma peritonei. J Dig Oncol (Electronic Version). 2025;17(2):195\u2013203.","journal-title":"J Dig Oncol (Electronic Version)"},{"key":"4221_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/bjs.10723","volume":"105","author":"G Passot","year":"2018","unstructured":"Passot G, Dumont F, Go\u00e9r\u00e9 D, Arvieux C, Rousset P, Regimbeau J, et al. Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE). Br J Surg. 2018;105:663\u20137.","journal-title":"Br J Surg"},{"key":"4221_CR53","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/SLA.0b013e31820784df","volume":"253","author":"J Esquivel","year":"2011","unstructured":"Esquivel J, Averbach A, Chua TC. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience. Ann Surg. 2011;253:764\u20138.","journal-title":"Ann Surg"},{"key":"4221_CR54","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1007\/s00464-022-09589-w","volume":"37","author":"CY Cho","year":"2023","unstructured":"Cho CY, Veerapong J, Baumgartner JM, Murphy JD, Lowy AM, Kelly KJ. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis. Surg Endosc. 2023;37:5644\u201351.","journal-title":"Surg Endosc"},{"key":"4221_CR55","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","volume":"92","author":"BM Ronnett","year":"2001","unstructured":"Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. 2001;92:85\u201391.","journal-title":"Cancer"},{"key":"4221_CR56","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/01.pas.0000202039.74837.7d","volume":"30","author":"RF Bradley","year":"2006","unstructured":"Bradley RF, Stewart JH 4th, Russell GB, Levine EA, Geisinger KR. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30:551\u20139.","journal-title":"Am J Surg Pathol"},{"key":"4221_CR57","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with Pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol"},{"key":"4221_CR58","doi-asserted-by":"publisher","first-page":"e206363","DOI":"10.1001\/jamasurg.2020.6363","volume":"156","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Barretta F, Yonemura Y, Sugarbaker PH, Moran BJ, Levine EA, et al. The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery. JAMA Surg. 2021;156:e206363.","journal-title":"JAMA Surg"},{"key":"4221_CR59","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.sla.0000133183.15705.71","volume":"240","author":"O Glehen","year":"2004","unstructured":"Glehen O, Mohamed F, Sugarbaker PH. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg. 2004;240:278\u201385.","journal-title":"Ann Surg"},{"key":"4221_CR60","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1463-1318.2009.01947.x","volume":"12","author":"P J\u00e4rvinen","year":"2010","unstructured":"J\u00e4rvinen P, J\u00e4rvinen HJ, Lepist\u00f6 A. Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis. 2010;12:868\u201372.","journal-title":"Colorectal Dis"},{"key":"4221_CR61","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.asjsur.2022.08.052","volume":"46","author":"C Wang","year":"2023","unstructured":"Wang C, Yin XY, An LB, Zhai XC, Cai Y, Shi GJ, et al. Significance of laparoscopic cytoreductive surgery for appendiceal Pseudomyxoma peritonei with limited disease and low tumor burden. Asian J Surg. 2023;46:1220\u20135.","journal-title":"Asian J Surg"},{"key":"4221_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12957-021-02171-z","volume":"19","author":"B Trilling","year":"2021","unstructured":"Trilling B, Brind\u2019Amour A, Hamad R, Tremblay JF, Dub\u00e9 P, Mitchell A, et al. Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei with high peritoneal carcinomatosis index. World J Surg Oncol. 2021;19:60.","journal-title":"World J Surg Oncol"},{"key":"4221_CR63","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/02656736.2020.1772511","volume":"37","author":"O Sgarbura","year":"2020","unstructured":"Sgarbura O, Al Hosni M, Petruzziello A, Figueroa R, Khellaf L, Pissas MH, et al. Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept. Int J Hyperthermia. 2020;37:585\u201391.","journal-title":"Int J Hyperthermia"},{"key":"4221_CR64","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1245\/s10434-023-14422-2","volume":"31","author":"N Bhutiani","year":"2024","unstructured":"Bhutiani N, Grotz TE, Concors SJ, White MG, Helmink BA, Raghav KP, et al. Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous appendiceal adenocarcinoma: A viable treatment strategy with demonstrable benefit. Ann Surg Oncol. 2024;31:614\u201321.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR65","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1245\/s10434-022-11440-4","volume":"29","author":"CD Valenzuela","year":"2022","unstructured":"Valenzuela CD, Mangieri CW, Garland-Kledzik M, Gawdi R, Russell G, Perry KC, et al. Timing of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for recurrent low-grade appendiceal mucinous neoplasms. Ann Surg Oncol. 2022;29:3422\u201331.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR66","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ejso.2013.08.017","volume":"39","author":"A Sardi","year":"2013","unstructured":"Sardi A, Jimenez WA, Nieroda C, Sittig M, Macdonald R, Gushchin V. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Eur J Surg Oncol. 2013;39:1207\u201313.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR67","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","volume":"20","author":"M Alyami","year":"2019","unstructured":"Alyami M, H\u00fcbner M, Grass F, Bakrin N, Villeneuve L, Laplace N, et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20:e368\u2013368377.","journal-title":"Lancet Oncol"},{"key":"4221_CR68","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","volume":"26","author":"W Solass","year":"2012","unstructured":"Solass W, Herbette A, Schwarz T, Hetzel A, Sun J, Dutreix M, et al. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc. 2012;26:847\u201352.","journal-title":"Surg Endosc"},{"key":"4221_CR69","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1245\/s10434-022-11577-2","volume":"29","author":"A Taibi","year":"2022","unstructured":"Taibi A, Sgarbura O, H\u00fcbner M, Bardet SM, Alyami M, Bakrin N, et al. Feasibility and safety of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy with or without intraoperative intravenous 5-fluorouracil and leucovorin for colorectal peritoneal metastases: a multicenter comparative cohort study. Ann Surg Oncol. 2022;29:5243\u201351.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR70","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1245\/s10434-020-09508-0","volume":"28","author":"N Tabchouri","year":"2021","unstructured":"Tabchouri N, Buggisch J, Demtr\u00f6der CR, Thiery J, Rezniczek G, Tempfer CB, et al. Pressurized intraperitoneal aerosol chemotherapy for colorectal peritoneal metastases. Ann Surg Oncol. 2021;28:5275\u201386.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR71","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919846402","volume":"11","author":"F Struller","year":"2019","unstructured":"Struller F, Horvath P, Solass W, Weinreich F, Strumberg D, Kokkalis MK, et al. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study. Ther Adv Med Oncol. 2019;11:1758835919846402.","journal-title":"Ther Adv Med Oncol"},{"key":"4221_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041125","author":"A Di Giorgio","year":"2023","unstructured":"Di Giorgio A, Macr\u00ec A, Ferracci F, Robella M, Visaloco M, De Manzoni G, et al. 10 years of pressurized intraperitoneal aerosol chemotherapy (PIPAC): a systematic review and meta-analysis. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15041125.","journal-title":"Cancers (Basel)"},{"key":"4221_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gore.2014.10.001","volume":"10","author":"CB Tempfer","year":"2014","unstructured":"Tempfer CB, Solass W, Buerkle B, Reymond M. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: a case report. Gynecol Oncol Rep. 2014;10:32\u20135.","journal-title":"Gynecol Oncol Rep"},{"key":"4221_CR74","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/jso.23547","volume":"109","author":"AU Blackham","year":"2014","unstructured":"Blackham AU, Swett K, Eng C, Sirintrapun J, Bergman S, Geisinger KR, et al. Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2014;109:740\u20135.","journal-title":"J Surg Oncol"},{"key":"4221_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1245\/s10434-024-16443-x","volume":"32","author":"M Stillman","year":"2025","unstructured":"Stillman M, Somasundar P, Espat NJ, Calvino AS, Kwon S. Negative impact of systemic therapy on survival in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade metastatic appendiceal adenocarcinoma. Ann Surg Oncol. 2025;32:221\u20139.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR76","doi-asserted-by":"publisher","first-page":"1456920","DOI":"10.3389\/fonc.2024.1456920","volume":"14","author":"SM Ruff","year":"2024","unstructured":"Ruff SM, Kasumova G, Palavalli M, Eng OS, Lambert L, Clarke C, et al. Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Front Oncol. 2024;14:1456920.","journal-title":"Front Oncol"},{"key":"4221_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082212","author":"A Prabhu","year":"2020","unstructured":"Prabhu A, Brandl A, Wakama S, Sako S, Ishibashi H, Mizumoto A, et al. Neoadjuvant intraperitoneal chemotherapy in patients with pseudomyxoma peritonei-a novel treatment approach. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12082212.","journal-title":"Cancers (Basel)"},{"key":"4221_CR78","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/SLA.0000000000005769","volume":"277","author":"S Reddy","year":"2023","unstructured":"Reddy S, Punjala SR, Allan P, Vaidya A, Borle DP, Geiele H, et al. First report with Medium-term Follow-up of intestinal transplantation for advanced and recurrent nonresectable Pseudomyxoma peritonei. Ann Surg. 2023;277:835\u201340.","journal-title":"Ann Surg"},{"key":"4221_CR79","doi-asserted-by":"crossref","unstructured":"Hamed N, Sara F, Mehdi LM, Reza SA, Mohammad E, Sadegh RM et al. Classic multivisceral transplant for advanced nonresectable Pseudomyxoma peritonei: a case report. J Med Case Rep. 2025;20:29.","DOI":"10.1186\/s13256-025-05748-4"},{"key":"4221_CR80","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ijc.28380","volume":"134","author":"K Pillai","year":"2014","unstructured":"Pillai K, Akhter J, Chua TC, Morris DL. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei. Int J Cancer. 2014;134:478\u201386.","journal-title":"Int J Cancer"},{"key":"4221_CR81","volume":"33","author":"A Amini","year":"2014","unstructured":"Amini A, Masoumi-Moghaddam S, Ehteda A, Morris DL. Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy. J Exp Clin Cancer Res. 2014;33:92.","journal-title":"J Exp Clin Cancer Res"},{"key":"4221_CR82","doi-asserted-by":"publisher","first-page":"33329","DOI":"10.18632\/oncotarget.5259","volume":"6","author":"A Amini","year":"2015","unstructured":"Amini A, Masoumi-Moghaddam S, Ehteda A, Liauw W, Morris DL. Depletion of mucin in mucin-producing human gastrointestinal carcinoma: results from in vitro and in vivo studies with Bromelain and N-acetylcysteine. Oncotarget. 2015;6:33329\u201344.","journal-title":"Oncotarget"},{"key":"4221_CR83","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejso.2019.10.033","volume":"47","author":"SJ Valle","year":"2021","unstructured":"Valle SJ, Akhter J, Mekkawy AH, Lodh S, Pillai K, Badar S, et al. A novel treatment of Bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study. Eur J Surg Oncol. 2021;47:115\u201322.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR84","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.21873\/anticanres.16670","volume":"43","author":"E Skalkos","year":"2023","unstructured":"Skalkos E, Chen KL, Wijayawardana R, Morris DL. Effective use of Bromelain and acetylcysteine (BromAc(\u00ae)) for treatment of perigastric pseudomyxoma peritonei: a case report. Anticancer Res. 2023;43:4735\u20138.","journal-title":"Anticancer Res"},{"key":"4221_CR85","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1159\/000534202","volume":"16","author":"J Yang","year":"2023","unstructured":"Yang J, Glenn D, Lodh S, Valle S, Morris DL. Long-term treatment of unresectable Pseudomyxoma peritonei with multiple treatments of intratumoural Bromelain and acetylcysteine (BromAc\u00ae): a case report. Case Rep Oncol. 2023;16:1551\u20136.","journal-title":"Case Rep Oncol"},{"key":"4221_CR86","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1245\/s10434-024-15355-0","volume":"31","author":"N Wajih","year":"2024","unstructured":"Wajih N, Erali RA, Forsythe SD, Schaaf CR, Shen P, Levine EA, et al. Enhancing the efficacy of HIPEC through Bromelain: a preclinical investigation in appendiceal cancer. Ann Surg Oncol. 2024;31:5377\u201389.","journal-title":"Ann Surg Oncol"},{"key":"4221_CR87","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1515\/pp-2025-0026","volume":"10","author":"C Vici","year":"2025","unstructured":"Vici C, Eapen M, Narang P, Morris DL. The addition of collagenase to bromac \u00ae for the management of inoperable Pseudomyxoma peritonei - in vitro results. Pleura Peritoneum. 2025;10:185\u201392.","journal-title":"Pleura Peritoneum"},{"key":"4221_CR88","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.12998\/wjcc.v7.i22.3881","volume":"7","author":"R Huang","year":"2019","unstructured":"Huang R, Shi XL, Wang YF, Yang F, Wang TT, Peng CX. Apatinib for treatment of a Pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: a case report. World J Clin Cases. 2019;7:3881\u20136.","journal-title":"World J Clin Cases"},{"key":"4221_CR89","first-page":"e1407","volume":"9","author":"C McGrath","year":"2017","unstructured":"McGrath C, Linden K, Hube P, Adamiak A, Dennis K. Palliative radiation therapy for symptom control in an advanced case of Pseudomyxoma peritonei. Cureus. 2017;9:e1407.","journal-title":"Cureus"},{"key":"4221_CR90","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00066-013-0470-7","volume":"190","author":"P Berkovic","year":"2014","unstructured":"Berkovic P, van de Voorde L, De Meerleer G, Delrue L, Speleers B, Van Belle S, et al. Whole abdominopelvic radiotherapy in the palliative treatment of Pseudomyxoma peritonei. Strahlenther Onkol. 2014;190:223\u20138.","journal-title":"Strahlenther Onkol"},{"key":"4221_CR91","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003109","volume":"9","author":"K Flatmark","year":"2021","unstructured":"Flatmark K, Torgunrud A, Fleten KG, Davidson B, Juul HV, Mensali N, et al. Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei. J Immunother Cancer. 2021;9:e003109.","journal-title":"J Immunother Cancer"},{"key":"4221_CR92","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1200\/JCO.24.00511","volume":"43","author":"J Weitz","year":"2025","unstructured":"Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, et al. Cyclin-dependent kinase 4\/6 inhibition as a novel therapy for peritoneal mucinous carcinomatosis with GNAS mutations. J Clin Oncol. 2025;43:705\u201315.","journal-title":"J Clin Oncol"},{"key":"4221_CR93","first-page":"e95246","volume":"17","author":"F Bowers Alexander","year":"2025","unstructured":"Bowers Alexander F, Dodson David M, Monson Alexander J, Courtney T, Aashish R. Torsion of appendiceal mucinous neoplasm: a rare cause of right lower quadrant abdominal pain. Cureus. 2025;17:e95246.","journal-title":"Cureus"},{"key":"4221_CR94","first-page":"e88200","volume":"17","author":"SGM Hernandez","year":"2025","unstructured":"Hernandez SGM, Cruz DN, Benitez LC, L\u00f3pez RMM, Olmedo AAZ, Curi-Curi PJ, et al. Appendiceal mucocele in amyand\u2019s hernia: A case report. Cureus. 2025;17:e88200.","journal-title":"Cureus"},{"key":"4221_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjaf864","volume":"2025","author":"K Ismayilzada","year":"2025","unstructured":"Ismayilzada K, Topgul K. Giant appendiceal mucocele (17 cm) treated by laparoscopic appendectomy: a rare presentation and review of the literature. J Surg Case Rep. 2025;2025:rjaf864.","journal-title":"J Surg Case Rep"},{"key":"4221_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2025.111488","volume":"132","author":"A Alakeel","year":"2025","unstructured":"Alakeel A, Mubarah A, Alshehri M, Alsannaa F. Incidental detection of appendiceal mucocele during colonoscopy: a case report. Int J Surg Case Rep. 2025;132:111488.","journal-title":"Int J Surg Case Rep"},{"key":"4221_CR97","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/bjs.5385","volume":"93","author":"EM Murphy","year":"2006","unstructured":"Murphy EM, Farquharson SM, Moran BJ. Management of an unexpected appendiceal neoplasm. Br J Surg. 2006;93:783\u201392.","journal-title":"Br J Surg"},{"key":"4221_CR98","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040599","volume":"103","author":"C Wang","year":"2024","unstructured":"Wang C, Jia Y, Shi G, An L, Fan X, Zhang P, et al. Prophylactic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous tumors with early and limited disease after completely removed. Medicine. 2024;103:e40599.","journal-title":"Medicine"},{"key":"4221_CR99","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/bjs.4393","volume":"91","author":"S Gonz\u00e1lez-Moreno","year":"2004","unstructured":"Gonz\u00e1lez-Moreno S, Sugarbaker PH. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg. 2004;91:304\u201311.","journal-title":"Br J Surg"},{"key":"4221_CR100","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.ejso.2021.05.015","volume":"47","author":"R Ma","year":"2021","unstructured":"Ma R, Lu D, Wang B, Zhai X, Xia A, An L, et al. Complete cytoreductive surgery vs. Debulking surgery for Pseudomyxoma peritonei of appendiceal origin: A propensity score-matched study based on a single-center experience. Eur J Surg Oncol. 2021;47:2369\u201376.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR101","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejso.2014.08.476","volume":"41","author":"AC Lord","year":"2015","unstructured":"Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Eur J Surg Oncol. 2015;41:396\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"4221_CR102","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1111\/codi.15778","volume":"23","author":"JC Kong","year":"2021","unstructured":"Kong JC, Flood MP, Guerra GR, Liesegang A, Wong WJ, Mitchell C, et al. Appendiceal Pseudomyxoma peritonei: predictors of recurrence and iterative surgery. Colorectal Dis. 2021;23:2368\u201375.","journal-title":"Colorectal Dis"},{"key":"4221_CR103","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211022297","volume":"49","author":"F Yan","year":"2021","unstructured":"Yan F, Shi F, Li X, Chang H, Jin M, Li Y. Prognostic significance of CEA, Ki67 and p53 in pseudomyxoma peritonei of appendiceal origin. J Int Med Res. 2021;49:3000605211022297.","journal-title":"J Int Med Res"},{"issue":"7","key":"4221_CR104","first-page":"543","volume":"48","author":"FC Yan","year":"2019","unstructured":"Yan FC, Lin YL, Zhao HY, Zhou Q, Chang H, Li Y. Analysis of pathological prognostic factors in 155 cases of pseudomyxoma peritonei. Chin J Pathol. 2019;48(7):543\u20139.","journal-title":"Chin J Pathol"},{"key":"4221_CR105","doi-asserted-by":"publisher","first-page":"102279","DOI":"10.1016\/j.tranon.2025.102279","volume":"53","author":"R Ma","year":"2025","unstructured":"Ma R, Li G, Ye Y, Liang L, Wang C, Zhou H, et al. Prognosis conferred by molecular features of appendix-derived Pseudomyxoma peritonei. Transl Oncol. 2025;53:102279.","journal-title":"Transl Oncol"},{"key":"4221_CR106","doi-asserted-by":"crossref","unstructured":"Zhao Q, Wei T, Ma R, Fu Y, Yang R, Su Y, et al. Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei. Cancer Biol Med. 2024;21(7):586\u2013605.","DOI":"10.20892\/j.issn.2095-3941.2024.0109"},{"key":"4221_CR107","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamasurg.2023.0112","volume":"158","author":"K Chandrakumaran","year":"2023","unstructured":"Chandrakumaran K, Carr NJ, Mohamed F, Cecil TD, Moran BJ. Development and validation of nomograms to predict survival in patients undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin. JAMA Surg. 2023;158:522\u201330.","journal-title":"JAMA Surg"},{"key":"4221_CR108","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7101","volume":"13","author":"R Ma","year":"2024","unstructured":"Ma R, Su YD, Yan FC, Lin YL, Gao Y, Li Y. A nomogram prediction model of pseudomyxoma peritonei established based on new prognostic factors of HE stained pathological images analysis. Cancer Med. 2024;13:e7101.","journal-title":"Cancer Med"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04221-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:03:54Z","timestamp":1771434234000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04221-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4221"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04221-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}